FDA Adverse Event Malfunction Summary report: N

INSPIRE 8F HOLLOW FIBER OXYGENATOR WITH INTEGRATED ARTERIAL FILTER AND HARDSHELL

MDR report key: 8335073 · Received February 13, 2019

Report

Report Number
9680841-2019-00004
Event Type
Malfunction
Date Received
February 13, 2019
Date of Event
December 20, 2018
Report Date
April 26, 2019
Manufacturer
SORIN GROUP ITALIA SRL
Product Code
DTZ
UDI-DI
08033178112383
PMA / PMN Number
K130433
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

THE AGE OF THE DEVICE WAS CALCULATED AS THE TIME ELAPSED BETWEEN DEVICE STERILIZATION AND THE DATE OF THE EVENT. (B)(4). SORIN GROUP (B)(6) MANUFACTURES THE INSPIRE 8F HOLLOW FIBER OXYGENATOR WITH INTEGRATED ARTERIAL FILTER AND HARDSHELL. THE INCIDENT OCCURRED (B)(6). PER EXEMPTION NUMBER E2016005. THE INVOLVED DEVICE HAS BEEN REQUESTED FOR RETURN TO SORIN GROUP (B)(6) FOR INVESTIGATION. IF ANY ADDITIONAL INFORMATION PERTINENT TO THE REPORTED EVENT IS RECEIVED, IT WILL BE PROVIDED IN A SUPPLEMENTAL REPORT.

Additional Manufacturer Narrative · 0

SORIN GROUP ITALIA MANUFACTURES THE INSPIRE 8F HOLLOW FIBER OXYGENATOR WITH INTEGRATED ARTERIAL FILTER AND HARDSHELL. THE INCIDENT OCCURRED IN TARTU, ESTONIA. PER EXEMPTION NUMBER E2016005, SORIN GROUP ITALIA S.R.L. IS SUBMITTING THE REPORT FOR BOTH SORIN GROUP ITALIA S.R.L (MANUFACTURER) AND LIVANOVA USA., INC. (IMPORTER). THE INVOLVED DEVICE HAS BEEN RETURNED TO THE MANUFACTURER AND SUBMITTED TO GAMMA RAY DECONTAMINATION PRIOR THE INSPECTION. THE VISUAL INSPECTION FOUND NO DEFECTS NOR NON-CONFORMITIES. BIOLOGICAL TRACES MAINLY COMPOSED BY RED DEPOSITS, LIKELY DUE TO FIBRIN DEPOSITION AND RED BLOOD CELLS, WERE VISIBLE IN THE ARTERIAL FILTER. THE REVIEW OF THE DEVICE HISTORY RECORD OF THE CLAIMED OXYGENATOR LOT CONFIRMED THAT THE DEVICE WAS RELEASED IN COMPLIANCE WITH MANUFACTURER SPECIFICATIONS. TO SUBMIT THE DEVICE TO TEST FOR TRANSMEMBRANE PRESSURE VERIFICATION, THE DEVICE WAS EXTENSIVELY RINSED. HOWEVER, IT WAS NOT POSSIBLE TO REMOVE MOST OF BIOLOGICAL TRACES. THE TEST REPRODUCED THE CLAIMED ISSUE, THE PRESSURE DROP VALUES MEASURED DURING OUR LABORATORY TEST WERE ABOVE DEVICE SPECIFICATIONS. BASED ON MEDICAL LITERATURE, IT CAN BE CONFIRMED THAT THE INCREASE OF PRESSURE DROP HAS BEEN ASSOCIATED WITH PLATELET ADHESION AND FIBRIN LAYER DEPOSITION INSIDE THE OXYGENATOR. THE MOST PROBABLE ROOT CAUSE OF PLATELET ADHESION AND FIBRIN DEPOSITION IS MULTI-FACTORIAL AND INCLUDE CLINICAL PROCEDURE (E.G SURGICAL MATERIAL), THERAPIES (E.G. ANTICOAGULANT PRESCRIPTION, HEPARIN COMPOSITION AND PRIMING COMPOSITION) AND PATIENT SPECIFIC HEALTH CONDITIONS. ACCORDING TO SIMILAR CASES PREVIOUSLY INVESTIGATED THE ORIGIN OF THE ACTIVATION AND INTERACTION APPEAR TO BE MULTI-FACTORIAL IN NATURE AND NOT DEVICE SPECIFIC. FOR THIS REASON, NO SPECIFIC CORRECTIVE ACTION HAS BEEN IDENTIFIED AT THE PRESENT DATE. LIVANOVA WILL KEEP MONITORING THE MARKET FOR SIMILAR EVENTS.

Description of Event or Problem · 0

SORIN GROUP (B)(6) HAS RECEIVED A REPORT THAT, 10 MINUTES AFTER THE BEGINNING OF A PROCEDURE, THE DELTA TRANS-MEMBRANE PRESSURE OF THE INSPIRE 8F OXYGENATOR ROSE TO 300 MMHG. THE MEDICAL TEAM ELECTED TO CHANGE-OUT RESERVOIR, OXYGENATOR AND EQUIPMENT. THE PROCEDURE WAS COMPLETED WITH NO ISSUE. THERE IS NO REPORT OF ANY PATIENT INJURY. ON (B)(6) 2019, SORIN GROUP (B)(6) HAS BEEN INFORMED THE CHANGE-OUT TOOK 5 MINUTES.

Description of Event or Problem · 0

SEE INITIAL REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
128262 INSPIRE 8F HOLLOW FIBER OXYGENATOR WITH INTEGRATED ARTERIAL FILTER AND HARDSHELL HOLLOW FIBER OXYGENATOR WITH INTEGRATED ARTERIAL FILTER AND HARDSHELL VENOUS/CAR DTZ SORIN GROUP ITALIA SRL 8F PH.I.S.I.O. 1810080097 08033178112383

Patients

Seq Age Sex Outcome Treatment
1 54 YR